Introduction: Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, with incidence rising due to increased ultraviolet exposure, an aging population, and a growing num-ber of immunocompromised individuals. Objectives: This review presents a comprehensive analysis of dermoscopic features of cSCC lesions, delineating distinct patterns of Bowen’s disease (BD) and invasive cSCC, including keratoacanthoma (KA). The primary outcome was the identification of dermoscopic patterns specific to cSCC, while the secondary endpoint involved determining the prevalence of these features across different subtypes. Methods: We selected studies including individuals with histopathologically proven cSCC who underwent dermoscopic evaluation. Studies with at least five cases of cSCC were included, with no constraint on the study design. Results: Our analysis reveals that BD typically exhibits white-to-yellow scales and glomeru-lar vessels, whereas KA is characterized by a layered architecture with a central keratin plug, an ivory-white peripheral zone, and a symmetrical distribution of hairpin vessels. In contrast, invasive cSCC demonstrates a progression from well-differentiated lesions with organized vascular patterns to poorly differentiated forms marked by chaotic, polymorphic vessels and predominant red hues. Conclusion: These distinct dermoscopic patterns serve as practical clinical guides for differentiating SCC grades of invasion and differentiation, thereby enhancing diagnostic accuracy and patient management.
Dermoscopy of Keratinizing Skin Tumors: Cutaneous Squamous Cell Carcinoma, Keratoacanthoma, and Bowen’s Disease / Traini, D. O.; Palmisano, G.; Di Stefani, A.; Longo, C.; Cappilli, S.; Suppa, M.; Peris, K.. - In: DERMATOLOGY PRACTICAL & CONCEPTUAL. - ISSN 2160-9381. - 16:1(2026), pp. 5871-5882. [10.5826/dpc.1601a5871]
Dermoscopy of Keratinizing Skin Tumors: Cutaneous Squamous Cell Carcinoma, Keratoacanthoma, and Bowen’s Disease
Longo C.;Suppa M.;
2026
Abstract
Introduction: Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, with incidence rising due to increased ultraviolet exposure, an aging population, and a growing num-ber of immunocompromised individuals. Objectives: This review presents a comprehensive analysis of dermoscopic features of cSCC lesions, delineating distinct patterns of Bowen’s disease (BD) and invasive cSCC, including keratoacanthoma (KA). The primary outcome was the identification of dermoscopic patterns specific to cSCC, while the secondary endpoint involved determining the prevalence of these features across different subtypes. Methods: We selected studies including individuals with histopathologically proven cSCC who underwent dermoscopic evaluation. Studies with at least five cases of cSCC were included, with no constraint on the study design. Results: Our analysis reveals that BD typically exhibits white-to-yellow scales and glomeru-lar vessels, whereas KA is characterized by a layered architecture with a central keratin plug, an ivory-white peripheral zone, and a symmetrical distribution of hairpin vessels. In contrast, invasive cSCC demonstrates a progression from well-differentiated lesions with organized vascular patterns to poorly differentiated forms marked by chaotic, polymorphic vessels and predominant red hues. Conclusion: These distinct dermoscopic patterns serve as practical clinical guides for differentiating SCC grades of invasion and differentiation, thereby enhancing diagnostic accuracy and patient management.| File | Dimensione | Formato | |
|---|---|---|---|
|
dp1601a5871.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Licenza:
[IR] creative-commons
Dimensione
1.63 MB
Formato
Adobe PDF
|
1.63 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




